Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Efficacy and Safety Study of Toremifene Citrate for the Prevention of Prostate Cancer in Men With High Grade Prostatic Intraepithelial Neoplasia (PIN)

NCT00106691 is registered in ClinicalTrials.gov with GTx as lead sponsor.

NCT NCT00106691
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00106691 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Efficacy and Safety Study of Toremifene Citrate for the Prevention of Prostate Cancer in Men With High Grade Prostatic Intraepithelial Neoplasia (PIN)
Lead sponsor
GTx
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2005
Completion date
February 28, 2010
Enrollment
1,589 (actual)
Sites
138

Conditions

As the registry lists them; a condition with its own page is linked.

preneoplastic conditions, prostatic intraepithelial neoplasia